In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning

EMBO Journal

Volumn 33, Issue 7, 2014, Pages 762-778

  Formentini, Laura ^a,b,c   Pereira, Marta P ^a   Sánchez Cenizo, Laura ^a,b,c   Santacatterina, Fulvio ^a,b,c   Lucas, José J ^a,b   Navarro, Carmen ^d   Martínez Serrano, Alberto ^a   Cuezva, José M ^a,b,c  

^a CSIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d Hospital Meixoeiro Edificio Anexo   (Spain)

Author keywords

brain preconditioning; energy metabolism; inhibitory factor 1 (IF1); mitochondria

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; ADENOSINE TRIPHOSPHATASE INHIBITORY FACTOR 1; CYTOCHROME C OXIDASE; DOXYCYCLINE; PROTEIN BCL XL; PROTEIN KINASE B; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; QUINOLINIC ACID; S6 KINASE; UNCLASSIFIED DRUG; ATPASE INHIBITORY PROTEIN; NEUROTOXIN; PROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN DAMAGE; BRAIN NERVE CELL; CELL DEATH; CELL ISOLATION; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLYCOLYSIS; IN VIVO STUDY; LOCOMOTION; METABOLISM; MITOCHONDRION; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANIMAL BEHAVIOR; ANIMAL MODEL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BRAIN; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MISSENSE MUTATION; NERVE CELL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BRAIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOLYSIS; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MODELS, ANIMAL; MUTATION, MISSENSE; NEURONS; NEUROTOXINS; OXIDATIVE PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEINS; QUINOLINIC ACID; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84898670670     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1002/embj.201386392     Document Type: Article

References (63)

1. Acin-Perez R, Fernandez-Silva P, Peleato ML, Perez-Martos A, Enriquez JA, (2008) Respiratory active mitochondrial supercomplexes. Mol Cell 32: 529-539
2. Alavian KN, Li H, Collis L, Bonanni L, Zeng L, Sacchetti S, Lazrove E, Nabili P, Flaherty B, Graham M, Chen Y, Messerli SM, Mariggio MA, Rahner C, McNay E, Shore GC, Smith PJ, Hardwick JM, Jonas EA, (2011) Bcl-x(L) regulates metabolic efficiency of neurons through interaction with the mitochondrial F(1)F(O) ATP synthase. Nat Cell Biol 13: 1224-1233
3. Andersen JL, Kornbluth S, (2013) The tangled circuitry of metabolism and apoptosis. Mol Cell 49: 399-410
4. Barrientos A, Fontanesi F, Diaz F, (2009) Evaluation of the mitochondrial respiratory chain and oxidative phosphorylation system using polarography and spectrophotometric enzyme assays. Curr Protoc Hum Genet 19: Unit19 13
5. Bisetto E, Comelli M, Salzano AM, Picotti P, Scaloni A, Lippe G, Mavelli I, (2013) Proteomic analysis of F1F0-ATP synthase super-assembly in mitochondria of cardiomyoblasts undergoing differentiation to the cardiac lineage. Biochim Biophys Acta 1827: 807-816
6. Bonora M, Bononi A, De Marchi E, Giorgi C, Lebiedzinska M, Marchi S, Patergnani S, Rimessi A, Suski JM, Wojtala A, Wieckowski MR, Kroemer G, Galluzzi L, Pinton P, (2013) Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle 12: 674-683
7. Brooks SP, Dunnett SB, (2009) Tests to assess motor phenotype in mice: a user's guide. Nat Rev Neurosci 10: 519-529
8. Cabezon E, Butler PJ, Runswick MJ, Walker JE, (2000) Modulation of the oligomerization state of the bovine F1-ATPase inhibitor protein, IF1, by pH. J Biol Chem 275: 25460-25464
9. Campanella M, Casswell E, Chong S, Farah Z, Wieckowski MR, Abramov AY, Tinker A, Duchen MR, (2008) Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab 8: 13-25 (Pubitemid 351859227)
10. Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ, (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19: 3248-3257 (Pubitemid 29174016)
11. Chen YB, Aon MA, Hsu YT, Soane L, Teng X, McCaffery JM, Cheng WC, Qi B, Li H, Alavian KN, Dayhoff-Brannigan M, Zou S, Pineda FJ, O'Rourke B, Ko YH, Pedersen PL, Kaczmarek LK, Jonas EA, Hardwick JM, (2011) Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J Cell Biol 195: 263-276
12. Chivasa S, Tome DF, Hamilton JM, Slabas AR, (2011) Proteomic analysis of extracellular ATP-regulated proteins identifies ATP synthase beta-subunit as a novel plant cell death regulator. Mol Cell Proteomics 10: M110 003905
13. Cogliati S, Frezza C, Soriano ME, Varanita T, Quintana-Cabrera R, Corrado M, Cipolat S, Costa V, Casarin A, Gomes LC, Perales-Clemente E, Salviati L, Fernandez-Silva P, Enriquez JA, Scorrano L, (2013) Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 155: 160-171
14. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME, (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241 (Pubitemid 27456390)
15. Davies KM, Anselmi C, Wittig I, Faraldo-Gomez JD, Kuhlbrandt W, (2012) Structure of the yeast F1Fo-ATP synthase dimer and its role in shaping the mitochondrial cristae. Proc Natl Acad Sci USA 109: 13602-13607
16. Davies KM, Strauss M, Daum B, Kief JH, Osiewacz HD, Rycovska A, Zickermann V, Kuhlbrandt W, (2011) Macromolecular organization of ATP synthase and complex I in whole mitochondria. Proc Natl Acad Sci USA 108: 14121-14126
17. Dey R, Moraes CT, (2000) Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells. J Biol Chem 275: 7087-7094 (Pubitemid 30146256)
18. Di Lisa F, Carpi A, Giorgio V, Bernardi P, (2011) The mitochondrial permeability transition pore and cyclophilin D in cardioprotection. Biochim Biophys Acta 1813: 1316-1322
19. Duchen MR, Surin A, Jacobson J, (2003) Imaging mitochondrial function in intact cells. Methods Enzymol 361: 353-389 (Pubitemid 36241007)
20. Faccenda D, Tan CH, Seraphim A, Duchen MR, Campanella M, (2013) IF1 limits the apoptotic-signalling cascade by preventing mitochondrial remodelling. Cell Death Differ 20: 686-697
21. Formentini L, Sánchez-Aragõ M, Sánchez-Cenizo L, Cuezva JM, (2012) The mitochondrial ATPase Inhibitory Factor 1 (IF1) triggers a ROS-mediated retrograde pro-survival and proliferative response. Mol Cell 45: 731-742
22. Fujikawa M, Imamura H, Nakamura J, Yoshida M, (2012) Assessing the actual contribution of IF1, an inhibitor of mitochondrial FoF1, to ATP homeostasis, cell growth, mitochondrial morphology and cell viability. J Biol Chem 287: 18781-18787
23. Galluzzi L, Blomgren K, Kroemer G, (2009) Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 10: 481-494
24. Galluzzi L, Kepp O, Kroemer G, (2012) Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol 13: 780-788
25. Garcia JJ, Morales-Rios E, Cortes-Hernandez P, Rodriguez-Zavala JS, (2006) The inhibitor protein (IF1) promotes dimerization of the mitochondrial F1F0-ATP synthase. Biochemistry 45: 12695-12703 (Pubitemid 44630855)
26. Giorgio V, Bisetto E, Soriano ME, Dabbeni-Sala F, Basso E, Petronilli V, Forte MA, Bernardi P, Lippe G, (2009) Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. J Biol Chem 284: 33982-33988
27. Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M, Glick GD, Petronilli V, Zoratti M, Szabo I, Lippe G, Bernardi P, (2013) Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci USA 110: 5887-5892
28. Gledhill JR, Montgomery MG, Leslie AG, Walker JE, (2007) How the regulatory protein, IF(1), inhibits F(1)-ATPase from bovine mitochondria. Proc Natl Acad Sci USA 104: 15671-15676 (Pubitemid 350035358)
29. Gross A, Pilcher K, Blachly-Dyson E, Basso E, Jockel J, Bassik MC, Korsmeyer SJ, Forte M, (2000) Biochemical and genetic analysis of the mitochondrial response of yeast to BAX and BCL-X(L). Mol Cell Biol 20: 3125-3136 (Pubitemid 30215025)
30. Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ, (2001) p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci USA 98: 9666-9670 (Pubitemid 32769360)
31. Hernlund E, Hjerpe E, Avall-Lundqvist E, Shoshan M, (2009) Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment. Mol Cancer Ther 8: 1916-1923
32. Husain I, Harris DA, (1983) ATP synthesis and hydrolysis in submitochondrial particles subjected to an acid-base transition. Effects of the ATPase inhibitor protein. FEBS Lett 160: 110-114
33. Iadecola C, Anrather J, (2011) Stroke research at a crossroad: asking the brain for directions. Nat Neurosci 14: 1363-1368
34. Johnson KM, Chen X, Boitano A, Swenson L, Opipari AW Jr, Glick GD, (2005) Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423. Chem Biol 12: 485-496 (Pubitemid 40588924)
35. Karin M, (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436 (Pubitemid 44050137)
36. Lapuente-Brun E, Moreno-Loshuertos R, Acin-Perez R, Latorre-Pellicer A, Colas C, Balsa E, Perales-Clemente E, Quiros PM, Calvo E, Rodriguez-Hernandez MA, Navas P, Cruz R, Carracedo A, Lopez-Otin C, Perez-Martos A, Fernandez-Silva P, Fernandez-Vizarra E, Enriquez JA, (2013) Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science 340: 1567-1570
37. Leslie NR, (2006) The redox regulation of PI 3-kinase-dependent signaling. Antioxid Redox Signal 8: 1765-1774 (Pubitemid 44726350)
38. Li B, Chauvin C, De Paulis D, De Oliveira F, Gharib A, Vial G, Lablanche S, Leverve X, Bernardi P, Ovize M, Fontaine E, (2012) Inhibition of complex I regulates the mitochondrial permeability transition through a phosphate-sensitive inhibitory site masked by cyclophilin D. Biochim Biophys Acta 1817: 1628-1634
39. Li RJ, Zhang GS, Chen YH, Zhu JF, Lu QJ, Gong FJ, Kuang WY, (2010) Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance. Ann Oncol 7: 1506-1514
40. Lippe G, Sorgato MC, Harris DA, (1988) Kinetics of the release of the mitochondrial inhibitor protein. Correlation with synthesis and hydrolysis of ATP. Biochim Biophys Acta 933: 1-11. (Pubitemid 18086625)
41. Lopez-Mediavilla C, Vigny H, Godinot C, (1993) Docking the mitochondrial inhibitor protein IF1 to a membrane receptor different from the F1-ATPase beta subunit. Eur J Biochem 215: 487-496 (Pubitemid 23224335)
42. Martinez-Serrano A, Bjorklund A, (1996) Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J Neurosci 16: 4604-4616 (Pubitemid 26251057)
43. Matsuyama S, Xu Q, Velours J, Reed JC, (1998) The Mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell 1: 327-336 (Pubitemid 128378881)
44. Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER, (1996) Control of memory formation through regulated expression of a CaMKII transgene. Science 274: 1678-1683 (Pubitemid 26414891)
45. Michels J, Kepp O, Senovilla L, Lissa D, Castedo M, Kroemer G, Galluzzi L, (2013) Functions of BCL-X L at the interface between cell death and metabolism. Int J Cell Biol 2013: 705294
46. Mihaylova MM, Shaw RJ, (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13: 1016-1023
47. Minauro-Sanmiguel F, Wilkens S, Garcia JJ, (2005) Structure of dimeric mitochondrial ATP synthase: novel F0 bridging features and the structural basis of mitochondrial cristae biogenesis. Proc Natl Acad Sci USA 102: 12356-12358 (Pubitemid 41266363)
48. Paumard P, Vaillier J, Coulary B, Schaeffer J, Soubannier V, Mueller DM, Brethes D, di Rago JP, Velours J, (2002) The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J 21: 221-230 (Pubitemid 34137284)
49. Pelicano H, Xu RH, Du M, Feng L, Sasaki R, Carew JS, Hu Y, Ramdas L, Hu L, Keating MJ, Zhang W, Plunkett W, Huang P, (2006) Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 175: 913-923 (Pubitemid 44969197)
50. Ravati A, Ahlemeyer B, Becker A, Klumpp S, Krieglstein J, (2001) Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-kappaB. J Neurochem 78: 909-919 (Pubitemid 32777991)
51. Sanchez-Arago M, Formentini L, Cuezva JM, (2013a) Mitochondria-Mediated Energy Adaption in Cancer: the H(+)-ATP Synthase-Geared Switch of Metabolism in Human Tumors. Antioxid Redox Signal 19: 285-298
52. Sanchez-Arago M, Formentini L, Martinez-Reyes I, Garcia-Bermudez J, Santacatterina F, Sanchez-Cenizo L, Willers IM, Aldea M, Najera L, Juarranz A, Lopez EC, Clofent J, Navarro C, Espinosa E, Cuezva JM, (2013b) Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers. Oncogenesis 2: e46
53. Sanchez-Cenizo L, Formentini L, Aldea M, Ortega AD, Garcia-Huerta P, Sanchez-Arago M, Cuezva JM, (2010) Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. J Biol Chem 285: 25308-25313
54. Santamaria G, Martinez-Diez M, Fabregat I, Cuezva JM, (2006) Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H + -ATP synthase. Carcinogenesis 27: 925-935
55. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ, (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13: 465-477
56. Shchepina LA, Pletjushkina OY, Avetisyan AV, Bakeeva LE, Fetisova EK, Izyumov DS, Saprunova VB, Vyssokikh MY, Chernyak BV, Skulachev VP, (2002) Oligomycin, inhibitor of the F0 part of H + -ATP-synthase, suppresses the TNF-induced apoptosis. Oncogene 21: 8149-8157 (Pubitemid 35454417)
57. Shen L, Zhi L, Hu W, Wu MX, (2009) IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation. Cell Death Differ 16: 603-612
58. Shin YK, Yoo BC, Chang HJ, Jeon E, Hong SH, Jung MS, Lim SJ, Park JG, (2005) Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res 65: 3162-3170 (Pubitemid 40524597)
59. Tomasetig L, Di Pancrazio F, Harris DA, Mavelli I, Lippe G, (2002) Dimerization of F0F1ATP synthase from bovine heart is independent from the binding of the inhibitor protein IF1. Biochim Biophys Acta 1556: 133-141 (Pubitemid 35379671)
60. Tomiyama A, Serizawa S, Tachibana K, Sakurada K, Samejima H, Kuchino Y, Kitanaka C, (2006) Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors Bax and Bak. J Natl Cancer Inst 98: 1462-1473 (Pubitemid 44605591)
61. Wittig I, Schagger H, (2009) Supramolecular organization of ATP synthase and respiratory chain in mitochondrial membranes. Biochim Biophys Acta 1787: 672-680
62. Wondrak GT, (2009) Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal 11: 3013-3069
63. Zhao X, Leon IR, Bak S, Mogensen M, Wrzesinski K, Hojlund K, Jensen ON, (2011) Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes. Mol Cell Proteomics 10: M110.000299